- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
HIPAA compliance remains in doubt
The healthcare industry is far from ready to conduct most Healthcare Insurance Portability and Accountability Act (HIPAA) standard transactions, according to a poll of 631 healthcare executives by the Healthcare Information and Management Systems Society
The healthcare industry is far from ready to conduct most Healthcare Insurance Portability and Accountability Act (HIPAA) standard transactions, according to a poll of 631 healthcare executives by the Healthcare Information and Management Systems Society (HIMSS) and Phoenix Health Systems. The poll, which was conducted during the second and third weeks of January, indicates that the mandated conversion to standardized transactions is being hampered by confusion over specifications and an inability to complete testing. A major stumbling block is the lack of standardized communication of financial and relative clinical data, according to the survey. More than three-quarters of respondents indicated that their organizations are ready to accept and transmit one or more standard transactions, but less than 50% of the industry respondents are ready to accept or transmit all standard transactions.
"Considering the slow progress reported since the fall 2003 survey, it is unlikely that we will see industry-wide compliance within the near future," said D'Arcy Guerin Gue, executive vice president of Phoenix Health Systems.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
